NCT05155878Recruiting
Prognostic Factors in Periampullary Tumors and Cysts
Prognostic Factors, Operative Care and Short and Long Term Outcomes for Cysts and Tumors in Pancreas and the Periampullary Region
Source: ClinicalTrials.gov · Last updated 5 Jan 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The project aims at analysing prognostic and predictive factors involved in diagnostics and surgical treatment of cysts and tumors in the pancreas and periampullary region using both clinical data and blood and tissue samples for biomarker development and validation.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 30 Nov 2021
- Start date
- 1 Sept 2021
- Primary completion date
- 1 Jan 2035
- Lead sponsor
- Umeå University
- NCT number
- NCT05155878
What you commit to
- Study type: Observational
- Planned participants: 500
- From 1 Sept 2021 to the primary completion date, 1 Jan 2035
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- No informed consent (and still alive at study initiation)
Who the study is looking for
- Recommended surgery for tumor or cyst in the pancreas or periampullary region
- Information avalible in electronic journal files
- Informed consent (or deceased for retrospective part of the study)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Surgical Clinic at Umeå University Hospital Coordinator of this site? Confirm its status | Umeå | Sweden | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.